Ronac Mamtani, MD, MSCE

faculty photo
David J. Vaughn MD Associate Professor in GU Oncology
Department: Medicine

Contact information
Perelman Center for Advance Medicine
10th Floor, South Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19147
Education
BS
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Wang X, Long JB, Rothen J, Aremu AO, Huang S, Soulos PR, Robinson TJ, Presley CJ, Goldberg SB, Mamtani R, Wang SY, Ma S, Dinan MA, Gross CP.: Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer. J Natl Cancer Inst Sep 2026.

Mamtani R, Squires P, Mojebi A, Hale B, Tzontcheva A, Hill-McManus D, Lai Y, Franco S, Frederickson A, Li H.: Neoadjuvant, adjuvant, and perioperative therapy comparisons in muscle-invasive bladder cancer: Clinical and methodological considerations for the interpretation of network meta-analytic findings. Urol Oncol Sep 2026.

Mayer M, Seewald NJ, Ulloa-Pérez E, Homet Moreno B, Ramamurthy C, Babcock A, Li H, Mamtani R.: Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study. Clin Genitourin Cancer 24: 102652, Aug 2026.

Su L, Chen L, Mamtani R, Betigeri S, Hubbard R, Burcu M.: Use of real-world evidence in the U.S. Food and Drug Administration and the European Medicines Agency approvals of oncology products supported by single-arm trials (2022-2025). Oncologist 31: oyag296, Aug 2026.

Liu H, Merhav D, Tabakovic N, Mamtani R, Khullar K, Christodouleas J.: Severe primary organ-related complications in patients with de novo metastatic cancer: implications for prophylactic local therapy. Clin Transl Radiat Oncol 60: 101238, Jul 2026.

Squires P, Meng K, Hu X, Turzhitsky V, Kao YH, Stuart J, Ramamurthy C, Li H, Mamtani R.: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice. Oncol Ther Jun 2026.

Mayer M, Seewald N, Babcock A, Homet Moreno B, Ramamurthy C, Li H, Mamtani R.: Untreated advanced urothelial carcinoma (aUC) in the modern treatment era: Patterns of care from a decade-long national cohort. 2026 American Society of Clinical Oncology Annual Meeting, Chicago IL. J Clin Oncol, 44, Jun 2026 Notes: "Poster Presentation"

Subramanian P, Shyamsunder S, Eshaghi K, Mamtani R, Litt HK.: Gaps in patient-facing information on artificial intelligence in cancer care: A cross-sectional analysis. 2026 American Society of Clinical Oncology Annual Meeting, Chicago IL. J Clin Oncol, 44, Jun 2026 Notes: "Oral Presentation"

Chow RD, Rothen J, Long JB, Soulos PR, Wang X, Mamtani R, Ma S, Kunst N, Dinan MA, Gross CP.: Medicare Insurance Type and Broad Genomic Profiling in Metastatic Cancer. JAMA Netw Open 9: e2614919, May 2026.

Martei YM, Chen K, Obasohan M, Mamtani R, Aakhus E, Shulman LN, Hubbard RA, Clark A.: Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancer. JNCI Cancer Spectr 10(3): pkag043, May 2026.

back to top
Last updated: 09/29/2026
The Trustees of the University of Pennsylvania